Mmmm, I'm not prepared to comment on what the FDA wants, as I remain highly, highly concerned by them, as a regulatory agency. Hopefully, they start addressing the deficit in stemcell expertise that exists in the FDA, let alone the conflict of interest issues, and restore confidence in the agency in this area.
Meh, FDA. Was the gold standard, now (potentially like gold, in the face of bitcoin?) looks more like the "old standard", globally.
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-100
-
- There are more pages in this discussion • 324 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2482 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 27045 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |